Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India [NA]

View source ↗

Summary

A clinical trial in India is currently recruiting to assess secondary cervical cancer prevention in vulnerable women co-infected with HPV and HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Irvine | Conditions: Cervical Cancer, Human Papillomavirus (HPV) Infection | NA | Status: RECRUITING